-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Biofrontera's Return On Capital Employed Overview
Biofrontera's Return On Capital Employed Overview
Benzinga Pro data, Biofrontera (NASDAQ:BFRI) reported Q3 sales of $4.32 million. Earnings fell to a loss of $2.57 million, resulting in a 201.88% decrease from last quarter. In Q2, Biofrontera brought in $4.46 million in sales but lost $850 thousand in earnings.
Why Is ROCE Significant?
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, Biofrontera posted an ROCE of -0.11%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Biofrontera is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.
For Biofrontera, a negative ROCE ratio of -0.11% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.
Upcoming Earnings Estimate
Biofrontera reported Q3 earnings per share at $-0.16/share, which beat analyst predictions of $-0.29/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Benzinga Pro data, Biofrontera (NASDAQ:BFRI) reported Q3 sales of $4.32 million. Earnings fell to a loss of $2.57 million, resulting in a 201.88% decrease from last quarter. In Q2, Biofrontera brought in $4.46 million in sales but lost $850 thousand in earnings.
Benzinga Pro Data,生物翅目纳斯达克(BFRI:BFRI)公布第三季度销售额为432万美元。利润下降至亏损257万美元,比上一季度下降了201.88%。在第二季度,Biofrontera带来了446万美元的销售额,但损失了85万美元的收益。
Why Is ROCE Significant?
为什么ROCE意义重大?
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, Biofrontera posted an ROCE of -0.11%.
已动用资本回报率是衡量年度税前利润相对于企业已动用资本的指标。收益和销售额的变化预示着公司净资产收益率的变化。较高的净资产收益率通常代表着一家公司的成功增长,也是未来每股收益更高的标志。较低的净资产收益率或负净资产收益率则表明情况正好相反。第三季度,Biofrontera的净资产收益率为-0.11%。
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.
请记住,虽然净资产收益率可以很好地衡量一家公司最近的表现,但它并不是一家公司在不久的将来盈利或销售额的高度可靠的预测指标。
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Biofrontera is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.
净资产收益率是比较类似公司资本配置有效性的有力指标。相对较高的净资产收益率表明,Biofrontera的运营效率可能比行业内的其他公司更高。如果公司以目前的资本水平产生高利润,其中一些资金可以再投资于更多的资本,这通常会带来更高的回报,并最终实现每股收益(EPS)的增长。
For Biofrontera, a negative ROCE ratio of -0.11% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.
对于Biofrontera,负的净资产收益率为-0.11%,表明管理层可能没有有效地配置他们的资本。有效的资本配置是一个积极的指标,表明一家公司将获得更持久的成功和有利的长期回报;随着时间的推移,糟糕的资本配置可能会拖累公司的业绩。
Upcoming Earnings Estimate
即将到来的收益预期
Biofrontera reported Q3 earnings per share at $-0.16/share, which beat analyst predictions of $-0.29/share.
Biofrontera公布第三季度每股收益为-0.16美元,超过分析师预测的-0.29美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧